A novel GRK2 inhibitor alleviates experimental arthritis through restraining Th17 cell differentiation-Reference-Cited by-同舟云学术

A novel GRK2 inhibitor alleviates experimental arthritis through restraining Th17 cell differentiation

Published:2023-01 Issue: Volume:157 Page:113997
ISSN:0753-3322
Container-title:Biomedicine & Pharmacotherapy
language:en
Short-container-title:Biomedicine & Pharmacotherapy

Author:

Tao Juan,Jiang Chunru,Guo Paipai,Chen Huijuan,Zhu Zhenduo,Su Tiantian,Zhou Weijie,Tai Yu,Han Chenchen,Ma Yang,Chen Jingyu,Sun Wuyi,Wang Yuanyuan,Wei Wei,Wang Qingtong

Publisher

Elsevier BV

Subject

Pharmacology,General Medicine

Reference46 articles.

1. Involvement of histamine 4 receptor in the pathogenesis and progression of rheumatoid arthritis;Abd-Allah;Int. Immunol.,2014

2. Clinical remission of rheumatoid arthritis in a multicenter real-world study in Asia-Pacific region;Sun;Lancet Reg. Health West Pac.,2021

3. Y. Chang,X.. Jia,F.. Wei CP-25, a novel compound, protects against autoimmune arthritis by modulating immune 12;15:100240.

4. S.A. Bakheet,M.A.. Ansari,A.. Nadeem. CXCR3 antagonist AMG487 suppresses rheumatoid arthritis pathogenesis and progression by shifting the Th17/Treg cell balance. Cell Signal. 109395.

5. Local and systemic effects of IL-17 in joint inflammation: a historical perspective from discovery to targeting;Miossec;Cell Mol. Immunol.,2021

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A fully human monoclonal antibody targeting Semaphorin 5A alleviates the progression of rheumatoid arthritis;Biomedicine & Pharmacotherapy;2023-12

2. CP-25 inhibits the hyperactivation of rheumatic synoviocytes by suppressing the switch in Gαs-Gαi coupling to the β2-adrenergic receptor;Cell Communication and Signaling;2023-11-30